XML 51 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2019
Accounting Policy [Line Items]  
Schedule of Significant Balance of Accounts Receivable The Company has not experienced any loss on its deposits of cash and cash equivalents. Included in current assets are significant balances of accounts receivable as follows:

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Astellas Pharma Inc. (“Astellas”)—Related party

 

 

17

%

 

 

74

%

AstraZeneca AB (“AstraZeneca”)

 

 

81

%

 

 

26

%

 

ASU 2016-02 [Member]  
Accounting Policy [Line Items]  
Schedule of Impacts Upon Adoption of New Guidance

The impacts to the select line items from the Company’s consolidated balance sheet upon adoption of the ASC 842 guidance are as follows (in thousands):

 

Balance Sheet Line Item

 

Nature of Adjustment

 

New Lease Guidance Adoption Adjustment

 

Assets

 

 

 

 

 

 

Property and equipment, net

 

Derecognition - build-to-suit lease assets - building shell, cost

 

$

(53,880

)

 

 

Derecognition - build-to-suit lease assets - building shell,

    accumulated depreciation

 

 

13,476

 

 

 

Change of useful life - leasehold improvements,

    accumulated depreciation

 

 

(38,877

)

Finance lease right-of-use assets

 

Recognition - finance lease ROU assets

 

 

49,597

 

Other assets

 

Recognition - operating lease ROU assets

 

 

730

 

Liabilities

 

 

 

 

 

 

Accrued and other current liabilities

 

Derecognition - deferred rent, current

 

 

(619

)

 

 

Derecognition - build-to-suit lease liabilities, current

 

 

(545

)

 

 

Recognition - operating lease liabilities, current

 

 

404

 

Finance lease liabilities, current

 

Recognition - finance lease liabilities, current

 

 

11,499

 

Long-term portion of lease obligations

 

Derecognition - build-to-suit lease liabilities, non-current

 

 

(95,613

)

Deferred rent

 

Derecognition - deferred rent, non-current

 

 

(3,038

)

Finance lease liabilities, non-current

 

Recognition - finance lease liabilities, non-current

 

 

49,884

 

Other long-term liabilities

 

Recognition - operating lease liabilities, non-current

 

 

250

 

Stockholders’ equity

 

 

 

 

 

 

Accumulated deficit

 

Cumulative decrease to accumulated deficit

 

$

8,688

 

ASU 2018-02 [Member]  
Accounting Policy [Line Items]  
Schedule of Impacts Upon Adoption of New Guidance The impacts, based on the aggregate portfolio approach, to the Company’s accumulated other comprehensive loss and accumulated deficit upon adoption of this guidance are as follows (in thousands):

 

 

Accumulated

Other

Comprehensive Loss

 

 

Accumulated Deficit

 

Balance at December 31, 2018

 

$

(2,281

)

 

$

(715,827

)

Impact of change in accounting principle

   upon adoption of ASU 2018-02

 

 

611

 

 

 

(611

)

Opening balance as of January 1, 2019

 

$

(1,670

)

 

$

(716,438

)

ASU 2016-01 [Member]  
Accounting Policy [Line Items]  
Schedule of Impacts Upon Adoption of New Guidance The impacts to the Company’s accumulated other comprehensive loss and accumulated deficit upon adoption of this guidance are as follows (in thousands):

 

 

 

Accumulated

Other

Comprehensive Loss

 

 

Accumulated Deficit

 

Balance at December 31, 2017

 

$

(1,795

)

 

$

(630,657

)

Impact of change in accounting principle

   upon adoption of ASU 2016-01

 

 

(1,250

)

 

 

1,250

 

Opening balance as of January 1, 2018

 

$

(3,045

)

 

$

(629,407

)